Orexo Submits New Drug Application to FDA for OX124, a High-Dose Rescue Medication for Opioid Overdose

OX124 is based on Orexo´s world-class drug delivery platform amorphOX® and is designed to reverse the effect of the most powerful synthetic opioids, such as fentanyl Synthetic opioids are behind 91 percent of all fatal opioid overdoses...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news